SEARCH

SEARCH BY CITATION

References

  • 1
    Dosa DM. A day in the life of Oscar the cat. N Engl J Med 2007; 357: 3289.
  • 2
    Raggam RB, Wagner J, Prüller F et al. Soluble Urokinase Plasminogen Activator Receptor (suPAR) predicts mortality in patients with Systemic Inflammatory Response Syndrome (SIRS). J Intern Med 2014. doi: 10.1111/joim.12238 [Epub ahead of print].
  • 3
    Kofoed K, Eugen-Olsen J, Petersen J, Larsen K, Andersen O. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. Eur J Clin Microbiol Infect Dis 2008; 27: 37583.
  • 4
    Hoenigl M, Raggam RB, Wagner J et al. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem 2013; 46: 2259.
  • 5
    Yilmaz G, Köksal I, Karahan SC, Mentese A. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome. Clin Biochem 2011; 44: 122730.
  • 6
    Koch A, Voigt S, Kruschinski C et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011; 15: R63.
  • 7
    Huttunen R, Syrjänen J, Vuento R et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 2011; 270: 3240.
  • 8
    Thunø M, Macho B, Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009; 27: 15772.
  • 9
    Mesotten D, Vanhorebeek I, Van den Berghe G. The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab 2008; 4: 496505.
  • 10
    Goldman N, Turra CM, Glei DA et al. Predicting mortality from clinical and nonclinical biomarkers. J Gerontol A Biol Sci Med Sci 2006; 61: 10704.
  • 11
    Rietz A, Spiers J. The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases. Br J Pharmacol 2012; 166: 122543.